Trial Profile
Pharmacokinetics, pharmacodynamics and efficacy of multiple escalating SC doses of ligelizumab versus omalizumab and placebo in patients with allergic asthma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2016
Price :
$35
*
At a glance
- Drugs Ligelizumab (Primary) ; Omalizumab
- Indications Allergic asthma
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 30 Apr 2014 New trial record